No menu items!

Ministry of Food and Drug Safety “Close cooperation with the US FDA on supply and demand of innovative products and medicines”

Share This Post

- Advertisement -

The Ministry of Food and Drug Safety has decided to work closely with regulatory agencies such as the US Food and Drug Administration (FDA).

From the 20th to the 23rd, Minister Oh Yoo-gyeong of the Ministry of Food and Drug Safety visited major food and drug regulatory and research institutes in the US to strengthen mutual cooperation for global leadership in the bio and digital health field, and to promote food and drug regulation, safety innovation, and export support measures. It was announced on the 29th that it was sought.

- Advertisement -

Based on the results of the visit to the United States, it plans to promote innovation in the food and drug regulatory system that promotes the development of bio and digital health products, a system that supports global expansion, and a drug rehabilitation system that realizes public safety.

Director Oh decided to continue close cooperation (R2R) between the Ministry of Food and Drug Safety and regulatory agencies on overall regulations by visiting regulatory agencies (FDA), research institutes (NCI), and regulatory science junior colleges (Regulatory Science Innovation Center).

- Advertisement -

They met with Dr. Robert M. Califf, head of the US FDA, to derive common interests from both countries, such as digital and AI-based innovative products and drug supply and demand management in times of crisis, and agreed to continue discussing ways to cooperate in the future.

With the National Cancer Institute (NCI), it was decided to promote the signing of a memorandum of understanding in the field of research to support commercialization and strengthen regulatory expertise, and to hold a joint symposium with NCI regulatory expert advisory, etc., to continue discussions on future cooperation plans.

In addition, a memorandum of understanding between the Korea Regulatory Science Center, a support organization that plans and oversees the regulatory science talent development project (R&D) promoted by the Ministry of Food and Drug Safety, and the Center for Excellence in Regulatory Science Innovation (M-CERSI) at the University of Maryland is promoted, It plans to foster global regulatory science young talent by providing opportunities to participate in the US regulatory science program.

Director Oh also held symposiums and meetings with experts in the US and Korean companies in the US to seek ways to support scientific and technological innovation and global advancement.

The bio/digital health symposium was held with the Korean American Pharmaceutical Manufacturers Association to share the latest scientific technology and innovative product development trends, and discuss support for global advancement.

Based on the discussions at the meeting with Korean pharmaceutical and bio venture companies located at the Cambridge Innovation Center (CIC), it plans to promote the formation of a global advisory group to strengthen expertise in reviewing and consulting innovative products.

Meeting with Korean food manufacturing and restaurant companies that have entered the US, they decided to find out how the domestic industry entered the US, find ways to support exports, and build a communication and cooperation network with Korean and US food expert organizations.

In addition, in order to find a solution to the domestic youth drug problem, Director Oh visited the Samaritan Daytop Village (Lehadaytop) youth-specific rehabilitation center, which successfully runs a treatment and rehabilitation program for drug addicts in the United States. Various rehabilitation programs such as residential rehabilitation programs and treatment communities were examined.

Based on this, the Ministry of Food and Drug Safety plans to establish a communication channel between specialized institutions in the two countries to share knowledge and experience and improve educational programs, and to continue cooperation between the two countries through exchanges of rehabilitation experts.

It plans to promote a pilot project of a Korean treatment and rehabilitation model by strengthening youth programs, such as operating the newly opened addiction rehabilitation center as a youth center, and transforming and introducing a residential rehabilitation program in the United States to suit the domestic situation.

Director Oh said, “With this business trip as an opportunity, we will continue to strengthen cooperation with US regulatory and research institutions to advance the domestic regulatory system in line with global standards.” “We will advance the food and drug management system by establishing a regulatory innovation 2.0 plan and introducing measures to prevent and rehabilitate drug addiction that fit the domestic situation.”

Source: Donga

- Advertisement -

Related Posts